Thursday , September 21 2017
Home / Precision Medicine

Precision Medicine

Roche, Foundation Medicine Blood Test Could Help Personalize Cancer Immunotherapy

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced presentations at the European Society for Medical Oncology (ESMO) Annual Meeting highlighting validation data for its novel assay to measure tumor mutational burden from blood (bTMB). These presentations will highlight retrospective data analysis from Roche/Genentech’s Phase II POPLAR and Phase III OAK studies …

Read More »

New Approach to Genetic Testing Leads to Dramatic Response in MET Fusion Lung Cancer

There are many ways a gene can be altered and there are many genes that, when altered, can cause cancer. Testing individually for each possible alteration in every cancer-related gene is not feasible as it would require hundreds of individual tests and many, many thousands of dollars. A University of …

Read More »

Mayo Clinic Researchers Identify Genes Fueling Neuroblastoma Spread

ROCHESTER, Minn. — For the first time, Mayo Clinic researchers and colleagues present data on how nervous system tumors, called neuroblastomas, spread. Their paper, published in Cancer Cell, clarifies the relationship between two genes that fuel the aggressive spread of neuroblastomas. Neuroblastoma is a cancer that most commonly affects children age …

Read More »

Delivers Medicine to Cancer Cells While Protecting Healthy Cells

Cancer treatments, including chemotherapy, have helped many of those who have been diagnosed with the disease to go on to live healthy lives. Nevertheless, chemotherapy takes a toll on the body. During treatment, chemotherapy attacks all of the body’s cells, not just cancer cells. The result destroys healthy cells, causing …

Read More »

Champions Oncology Enters Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of PDX Models

HACKENSACK, N.J., Aug. 21, 2017 /PRNewswire/ — Champions Oncology, Inc. (NASDAQ: CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced a strategic collaboration with AstraZeneca to develop novel cohorts of PDX models. These …

Read More »

Scientists Develop Blood Test That Spots Tumor-Derived DNA in People With Early-Stage Cancers

In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively …

Read More »

NYITCOM Researcher Discovers Potential Cancer Treatment Breakthrough

Patients undergoing conventional chemotherapy for certain cancers could potentially receive more effective and less toxic drug treatment. In a July issue of the journal Proceedings of the National Academy of Sciences (PNAS), Dong Zhang Ph.D., associate professor of Biomedical Sciences at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) and a team …

Read More »

NCI Study Identifies Essential Genes for Cancer Immunotherapy

A new study identifies genes that are necessary in cancer cells for immunotherapy to work, addressing the problem of why some tumors don’t respond to immunotherapy or respond initially but then stop as tumor cells develop resistance to immunotherapy. The study, from the National Cancer Institute (NCI), was led by Nicholas …

Read More »

Brain Tumor Scientists Map Mutation that Drives Tumors in Childhood Cancer Survivors

(TORONTO, Canada – Aug. 4, 2017) – Neuroscientists have uncovered the genetic basis for why many long-term survivors of childhood cancer develop meningiomas, the most common adult brain tumor, decades after their treatment with cranial radiation. The findings, published online today in Nature Communications, show that radiation causes genetic rearrangements in …

Read More »

New Research Shows the Power of Radiomics to Improve Precision Medicine

TAMPA, Fla. (Aug. 3, 2017) – Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules. Despite the progress that has been made in targeted cancer therapies, the path has been slow and scientists have …

Read More »